Skip to main content
. 2017 Sep 14;8(46):80666–80678. doi: 10.18632/oncotarget.20881

Table 2. Clinical characteristics of the subjects (n = 40).

Variables: median (range) Healthy control (n= 10) HCC (n = 30) P-value
Sex (M/F) 6/4 18/12 P = 1.0
Age (years) 53.0 ± 2.2 54.3 ± 2.4 P = 0.36
ALT 27.4 38.5 P = 0.031
AST 25.7 40.2 P = 0.026
AFP (ng/ml) 2.8 1083.8 P < 0.001
HBsAg-positive 2 24 P < 0.001
Tumour size (cm) 4.5
Tumour number (1/2/3 ∼) 21/5/4
Capsule invasion (+/−) 9/21
TNM stage (I–II/III–IV) 6/24